foxo4 dri senolytic or senomorphic
foxo4 dri senolytic or senomorphic FOXO4-DRI Dosing: 1mg Protocol (2026) Senotherapy for chronic lung disease
Senotherapy for chronic lung disease Pharmacological Reviews Targeting Cellular Senescence in Aging and Age Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies CHK2 USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis PNAS The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
USD23.06
USD52.06
Pay in 4 interest-free payments of $5.76 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
